The GLP-1-Mitochondria Axis in Metabolic Aging. [PDF]
Chang R, Tsai AP, Wang B, Li CJ.
europepmc +1 more source
Global Landscape and Thematic Evolution of Selective GLP-1 Receptor Agonists and GLP-1-Based Multi-Receptor Agonists in Type 2 Diabetes Mellitus: A Bibliometric Analysis. [PDF]
Wang Y +6 more
europepmc +1 more source
IDE-mediated GLP-1 degradation as the basis for designing long-acting and CNS-stable GLP-1 receptor agonists. [PDF]
Zhang L +9 more
europepmc +1 more source
The Expanding Role of GLP-1 Receptor Agonists and Dual GIP/GLP-1 Agonists in Dermatology: From Immunometabolism to Clinical Practice. [PDF]
Giorgio CM +10 more
europepmc +1 more source
Correction: Incretin-Based Therapies in Doxorubicin-Induced Cardiotoxicity: A Systematic Review of GLP-1 and Dual GIP/GLP-1 Agonists. [PDF]
Khatami S +4 more
europepmc +1 more source
GLP-1 receptor agonists-a potential therapy for chronic kidney disease? [PDF]
Boeckhaus J, Sayer JA, Mabillard H.
europepmc +1 more source
Impact of GLP-1 and GLP-1/GIP receptor agonists before, during, and after pregnancy: a narrative review. [PDF]
Zajdenverg L +4 more
europepmc +1 more source
Cardiovascular protection beyond glucose lowering: GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonism in contemporary cardiology. [PDF]
Li M.
europepmc +1 more source
Effect of GLP-1 receptor agonist on nutrient intake: A narrative review. [PDF]
Fujioka K.
europepmc +1 more source

